AMENDMENT OF EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances
THIS AMENDMENT OF EMPLOYMENT AGREEMENT between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Sandra Milligan (“Executive,” and together with the Company, the “Parties”) is effective as of September 1, 2024
SECOND AMENDMENT OF EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances
THIS SECOND AMENDMENT OF EMPLOYMENT AGREEMENT (this “Second Amendment”) between Aspira Women’s Health Inc., a Delaware corporation (the “Company”), and Nicole Sandford (“Executive,” and together with the Company, the “Parties”) is effective as of September 1, 2024 (the “Second Amended Restated Effective Date”).
CONSULTING AGREEMENTConsulting Agreement • August 13th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • California
Effective as of August 15, 2024 (the “Effective Date”), Aspira Women’s Health Inc. (the “Company”), and John Kallassy (“Consultant”) agree as follows:
